POLA2

POLA2 is the accessory (B) subunit of the DNA polymerase α/primase complex and supports genome replication, telomere maintenance, and double-strand break repair (PMID:28934486, PMID:32549188, PMID:39616267). Its central OB-fold domain is the principal docking site for STN1, whose N-terminal OB fold binds POLA2 directly; in the substrate-free primase–Pol α complex this domain is positioned to occlude nucleic acid entry to the Pol α active site, and the STN1–POLA2 interaction drives the conformational change that stimulates primase–Pol α activity and enables nucleic acid delivery to the active site (PMID:28934486). Consistent with this role in completing replication, biallelic loss-of-function variants in POLA2 cause a telomere biology disorder with Coats plus features and abnormally short telomeres, reflecting impaired telomere C-strand fill-in (PMID:39616267). Beyond replication, POLA2 also restrains spontaneous DSB formation and is required for efficient DSB repair through both NHEJ and homologous recombination, such that its loss sensitizes cells to ionizing radiation and PARP1 inhibition (PMID:32549188).

1. 2017 High

   Established the molecular basis by which the telomere factor STN1 engages the Pol α/primase machinery, answering how STN1 stimulates primase–Pol α activity.

   Evidence Purified protein binding and domain-mapping with in vitro primase–Pol α activity assays using STN1 variants

   PMID:28934486

   Open questions at the time

   • The proposed STN1-driven conformational change in POLA2's OB fold is inferred from structural context, not captured in a bound structure
   • Does not establish how this interaction is regulated in vivo at telomeres versus bulk replication
2. 2020 Medium

   Showed that POLA2 has a role in genome stability beyond primer synthesis, by linking its loss to DSB accumulation and impaired repair.

   Evidence siRNA knockdown with γH2AX foci, neutral comet, NHEJ and HR reporter assays, and clonogenic survival after IR and PARP1 inhibition

   PMID:32549188

   Open questions at the time

   • Whether the repair defects are direct or secondary to defective replication is not resolved
   • No physical partner or molecular mechanism placing POLA2 within NHEJ or HR machinery identified
3. 2024 Medium

   Connected POLA2 loss-of-function to human disease, establishing it as a causative gene for a telomere biology disorder.

   Evidence Whole-genome sequencing, segregation analysis, and telomere length measurement in two unrelated families

   PMID:39616267

   Open questions at the time

   • Telomere C-strand fill-in mechanism is inferred from genetics rather than directly reconstituted with patient variants
   • Genotype–phenotype relationship across the variant spectrum not characterized
4. 2024 Low

   Examined POLA2's contribution to cancer cell proliferation, raising the possibility of a role in proliferative signaling.

   Evidence siRNA/shRNA knockdown in HCC lines with proliferation, cell cycle, and Western blot for PI3K/AKT/mTOR components

   PMID:37861044

   Open questions at the time

   • PI3K/AKT/mTOR link rests solely on Western blot correlation after knockdown with no direct mechanistic validation
   • Single cell-line context; causal direction unresolved

• How POLA2's roles in replication, telomere C-strand fill-in, and DSB repair are mechanistically coordinated, and whether its repair function is direct, remains unresolved.
• No structure of the STN1-bound, activated primase–Pol α complex
• No defined physical link between POLA2 and NHEJ/HR factors
• Mechanism of telomere-specific recruitment unestablished